ロード中...
Carfilzomib in Combination with Bortezomib Enhances Apoptotic Cell Death in B16-F1 Melanoma Cells
SIMPLE SUMMARY: The incidence rate of metastatic melanoma has been rapidly increasing worldwide and its 5-year survival rate is very low. Due to partial responses, various side effects, and resistance to any known cancer therapeutics, more potent and safer therapeutics are needed to increase the sur...
保存先:
| 出版年: | Biology (Basel) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7918982/ https://ncbi.nlm.nih.gov/pubmed/33671902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biology10020153 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|